Page 3 - Immvira Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immvira pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immvira Pharma Today - Breaking & Trending Today

ImmVira's breakthrough intravenous oncolytic virus product MVR-T3011 IV completed first dosing in Phase I clinical trial in China

/PRNewswire/ Following its robust safety data in the U.S. Phase I clinical study, ImmVira announced that its global first intravenous administered oncolytic. ....

United States , Grace Zhou ,

ImmVira's breakthrough intravenous oncolytic virus product MVR-T3011 IV completed first dosing in Phase I clinical trial in China

/PRNewswire/ Following its robust safety data in the U.S. Phase I clinical study, ImmVira announced that its global first intravenous administered oncolytic. ....

United States , Grace Zhou ,

ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors

/PRNewswire/ Demonstrating innovation leadership on a global level, ImmVira announced that, its custom-designed new-generation oncolytic herpes simplex. ....

ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors

/PRNewswire/ Demonstrating innovation leadership on a global level, ImmVira announced that, its custom-designed new-generation oncolytic herpes simplex. ....

ImmVira's MVR-T3011 IV completed first 2 cohorts dose-escalation of U.S. Phase I clinical study with favorable safety data

/PRNewswire/ ImmVira s breakthrough product MVR-T3011 IV, global first clinical-stage oncolytic herpes simplex virus (oHSV) via intravenous injection, has. ....

Prnewswire Immvira , Guoying Zhou ,